REGONOL Trademark

Trademark Overview

On Wednesday, June 21, 2006, a trademark application was filed for REGONOL with the United States Patent and Trademark Office. The USPTO has given the REGONOL trademark a serial number of 78912946. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 20, 2018. This trademark is owned by Novartis AG. The REGONOL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for human use, namely, cholinesterase inhibitors, cholinergics, urologics, and gastrointestinal preparations
regonol

General Information

Serial Number78912946
Word MarkREGONOL
Filing DateWednesday, June 21, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 20, 2018
Registration Number3357938
Registration DateTuesday, December 18, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations for human use, namely, cholinesterase inhibitors, cholinergics, urologics, and gastrointestinal preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 20, 2018
Primary Code005
First Use Anywhere DateFriday, October 31, 2003
First Use In Commerce DateFriday, October 31, 2003

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Friday, July 20, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, December 18, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 18, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, December 18, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, December 8, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, December 18, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, December 8, 2013TEAS SECTION 8 & 15 RECEIVED
Friday, July 24, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 24, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 9, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 9, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 18, 2007REGISTERED-PRINCIPAL REGISTER
Friday, November 9, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, November 9, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 7, 2007STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 24, 2007USE AMENDMENT FILED
Wednesday, October 24, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, May 15, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2007NOTICE OF PUBLICATION
Thursday, December 21, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 21, 2006ASSIGNED TO LIE
Thursday, December 7, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 4, 2006EXAMINERS AMENDMENT MAILED
Monday, December 4, 2006EXAMINER'S AMENDMENT ENTERED
Monday, December 4, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 22, 2006NON-FINAL ACTION MAILED
Wednesday, November 22, 2006NON-FINAL ACTION WRITTEN
Tuesday, November 21, 2006ASSIGNED TO EXAMINER
Tuesday, June 27, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

regonol preparations cholinergics urologics gastrointestinal inhibitors cholinesterase human namely pharmaceutical